Key indicators: single-crystal X-ray study; T = 120 K; mean (C-C) = 0.009 Å; R factor = 0.054; wR factor = 0.163; data-to-parameter ratio = 14.3. 
The molecule of the title compound, C 11 H 8 BrN 3 O, is close to planar (r.m.s. deviation of all 16 non-H atoms = 0.103 Å ), a conformation stabilized by an intramolecular N-HÁ Á ÁN hydrogen bond, which generates an S(5) ring. In the crystal structure, supramolecular chains mediated by C-HÁ Á ÁO contacts (along a) are linked into a double layer via NÁ Á ÁBr halogen bonds 
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Comment
Pyrazinamide has well known anti-mycobacterial activity and is the one of the most important drugs used in tuberculosis treatment (Chaisson et al., 2002; Gordin et al., 2000; de Souza, 2006) . In continuation of our studies on pyrazinamide derivatives (Wardell et al., 2008; Baddeley et al., 2009; Howie et al., 2010a,b,c,d) , we report the structure of N-(4-bromophenyl)pyrazine-2-carboxamide, the title compound, (I). Experimental N-(4-Bromophenyl)pyrazine-2-carboxamide was prepared following the general procedure for N-arylpyrazine-2-carboxamides (Wardell et al., 2008) . Yield: 48%; m.p. 473 K, lit. value 471-474 K (Vontor et al., 1989) . The colourless plate of (I) used for the structure determination was grown from the slow evaporation of its ethanol solution.
Refinement
The C-bound H atoms were geometrically placed (C-H = 0.95 Å) and refined as riding with U iso (H) = 1.2U eq (C). The N-bound H atom was located from a difference map and refined with the distance restraint N-H = 0.88 (1) Å, and with U iso (H) = 1.2U eq (N).
Figures Fig. 1 . The molecular structure of (I) showing displacement ellipsoids at the 50% probability level.
supplementary materials sup-2 as those based on F, and R-factors based on ALL data will be even larger. 
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